News | June 13, 2013

Mirada Medical PET/MRI Software is Highlighted in Multiple Research Studies

Mirada’s software PET/MRI is an alternative to hybrid scanners

Mirada Medical PET/MRI Software is Highlighted in Multiple Research Studies

June 13, 2013 — Mirada Medical collaborators presentnew positron emission tomography/magnetic resonance imaging (PET/MRI) research.

PET/MRI is a rapidly developing field and Mirada is working to provide the software tools to support the research and trials necessary to realize the potential of the new modality in molecular imaging. The software supports both the hardware hybrid scanners and provides validated deformable registration for software based PET/CT(computed tomorgraphy)/MRI.

David Townsend, professor and director of the A*STAR-NUS Clinical Imaging Research Centre (CIRC) in Singapore, recently presented a paper entitled “Initial results of the assessment of PET/MR compared to PET/CT for diagnosis and staging of malignant disease.” This work is a comparative analysis of the image quality and quantification accuracy of hardware PET/MRI and PET/CT, a highly relevant topic of current interest in the field. Advanced quantification features and accurate deformable registration in Mirada PET/MRI software allowed the quantification of regions-of-interest simultaneously in both the PET/MRI and PET/CT of the same patient.

Another quantification analysis is presented in the work of Dr.Thomas Klausen of Rigshospitalet, Denmark, entitled “Image distortions and bias from dental restorations in PET/CT- and PET/MR-imaging.” In this work, Mirada’s support for multiple studies and multiple sequences enabled the analysis of artifacts arising from dental fillings on image quality and quantification on hardware PET/MRI and PET/CT.

Mirada’s software PET/MRI is an alternative to hybrid scanners and is based on deformable registration between the PET/CT and MRI to perform the fusion. A high-quality registration is critical for effective fusion between PET/CT and MRI. Mirada’s deformable registration algorithm, is the subject of another paper by Dr. Martin Lodge of Johns Hopkins University entitled “Combined PET/CT/MRI of the pelvis using software registration.” This work investigates the accuracy of the deformable registration between the CT and MR in the pelvis.

For more information: www.mirada-medical.com

 

Related Content

GE Healthcare and Theragnostics Partnering on PSMA PET/CT Imaging Agent
News | Prostate Cancer | October 16, 2019
GE Healthcare and Theragnostics have entered into a global commercial partnership for a new prostate-specific membrane...
ASNC Announces Multisocietal Cardiac Amyloidosis Imaging Consensus
News | Cardiac Imaging | September 09, 2019
September 9, 2019 — The American Society of Nuclear Cardiology (ASNC) published a new expert consensus document along
A 3-D printed tungsten pre-clinical X-ray system collimator. 3D printed, additive manufacturing for medical imaging.

A 3-D printed tungsten pre-clinical X-ray system collimator. The tungsten alloy powder is printed into the form desired and is laser fused so it can be machined and finished. Previously, making collimators from Tungsten was labor intensive because it required working with sheets of the metal to create the collimator matrix. 

Feature | Medical 3-D Printing | September 04, 2019 | By Steve Jeffery
In ...
A SPECT nuclear scan of the heart to show perfusion defects in the myocardium due to coronary artery blockages or heart attack. The imaging uses the Mo-99 based medical imaging isotope Tc-99m. The U.S. government has created policy to move away from use of highly enriched uranium (HEU) to low-enriched uranium (LEU) for Mo-99 isotope production, but there is one hold out who has not yet converted before a 2020 deadline. Photo courtesy of Philips Healthcare.

A SPECT nuclear scan of the heart to show perfusion defects in the myocardium due to coronary artery blockages or heart attack. The imaging uses the Mo-99 based medical imaging isotope Tc-99m. The U.S. government has created policy to move away from use of highly enriched uranium (HEU) to low-enriched uranium (LEU) for Mo-99 isotope production, but there is one holdout who has not yet converted before a 2020 deadline. Photo courtesy of Philips Healthcare.

Feature | Nuclear Imaging | August 30, 2019 | Dave Fornell, Editor
In a surprising move, the National Institute for Radioelements (IRE) has applied for a new license to export highly e
University of Alabama at Birmingham Leading Production of Theranostic Radioisotope

Image courtesy of the University of Alabama at Birmingham

News | Radiopharmaceuticals and Tracers | August 29, 2019
The University of Alabama at Birmingham, in conjunction with researchers at the University of Wisconsin and Argonne...
United Imaging Announces First U.S. Clinical Installation of uExplorer Total-body PET/CT
News | PET-CT | August 15, 2019
United Imaging announced that its uExplorer total-body positron emission tomography/computed tomography (PET/CT) system...
ASRT Supports Radiopharmaceutical Reimbursement Bill
News | Radiopharmaceuticals and Tracers | August 02, 2019
The American Society of Radiologic Technologists (ASRT) announced its support for House Resolution (HR) 3772, a measure...
International Multidisciplinary Group Publishes Recommendations for Personalized HCC Treatment With Y90 TheraSphere
News | Interventional Radiology | July 31, 2019
New consensus recommendations for personalized treatment for hepatocellular carcinoma (HCC) with BTG’s TheraSphere have...
NorthStar Medical Radioisotopes Awarded $30 Million by U.S. Department of Energy
News | Radiopharmaceuticals and Tracers | July 26, 2019
NorthStar Medical Radioisotopes LLC has been awarded $15 million in a cooperative agreement with the U.S. Department of...